1) Soskolne, W.A. and Shear, M.: Observations on the pathogenesis of primordial ysts. Brit. Dent. J., 123:321-327, 1967.
 
2) Soskolne, W.A.: Bilateral dilatation of the submandibular ducts. J. South Afr. Dent. Ass. 22:241-243, 1967.
 
3) Soskolne, W.A.: Iron deposits in giant cell granulomas of the alveolar process. Dent. Res. 50:678-679, 1971.
 
4) Soskolne, W.A.: Ultrastructure of the peripheral giant cell granuloma. J. Dent. Res. 50:1193-1194, 1971.
 
5) Soskolne, W.A.: Some observations on the pathogenesis and morphology of giant cell granulomas. Proc. Roy. Soc. Med. 65:1131-1134, 1972.

6) Soskolne, W.A.: Peripheral giant cell granulomas: anultrastructural study of three lesions. J. Oral Path. 1:133-143, 1972.
 
7) Gay, I., Sela, J., Ulmansky, M. and Soskolne, W.A.: Ossifying fibroma: report of a case. J. Oral Surg. 33:368-371, 1975.
 
8) Sela, J., Ulmansky, M., Sela, M., Yaffe, A. and Soskolne, W.A.: The effect of local anaesthetic solutions on the blood vessels of the rat molar. Pharac. and Therapeutics in Dentistry 2:245-252, 1975.
 
9) Azaz, B., Shteyer, A. and Soskolne, W.A.: Fibro-osseous lisions of the jaws: a report of two cases. J. Oral Med. 31:19-23, 1976.
 
10) Soskolne, W.A., Bab, I. and Shochat, S.: The production of keratinizing cysts within the mandibles of rats using autogenous gingival epithelial grafts: a histological study. J. Oral Path. 5a;122-128, 1976.
 
11) Soskolne, W.A., Lustmann, J. and Azaz, B.: Histiocytosis X: a report of six cases presenting in the jaws. J. Oral Surg. 35:30-33, 1977.
 
12) Stabholz, A., Brayer, L., Gedalia, I., Yosipovitch, Z. and Soskolne, W.A.:  Effect of fluoride on autogenous illiac cancellous bone and marrow transplants in surgically created intrabony pockets in dogs. J. Periodontol. 48:413-417, 1977.
 
13) Soskolne, W.A. and Shteyer, A.: Median Mandibullar cyst.Oral Surg. 44:84-88, 1977. 

14) Soskolne, W.A. and Bimstein, E.: A histomorphological study of the shedding process of human dediduous teeth at various chronological stages. Arch. Oral Biol. 22:331-335, 1977.
 
15) Lustman, J., Soskolne, W.A. and Lewin-Epstein, J.: An unusual case of central giant cell granuloma and periapical fibrous dysplasia occurring in the same jaw.Int. J. Oral Surg.7:11-15, 1978.
 
16) Horowitz, M. and Soskolne, W.A.: The cellular dynamics of rat submaxillary gland during heat acclimatization. J. Appl.Physiol. 44:21-24, 1978.
 
17) Soskolne, W.A.: Phagocytosis of osteocytes by osteoclasts in femora of two week old rattits. Cell Tiss. Res., 195:557-564,1978.
 
18) Soskolne, W.A. and Horowit, M.: effects of heat acclimation on the secretary products of the submaxillary gland of the rat. Cell Tiss. Res., 196:147-152, 1979.
 
19) Soskolne, W.A.: The osteoclast, endothelium interface during bone resorption in the femurs of young rabbits. Cell Tiss.Res., 203:487-492, 1979.
 
20) Geddalia, I. Soldinger, M., Azaz, B. and Soskolne, W.A.: Fluoride concentrations in fissure and cervical enamel of unerupted human teeth. J. Oral Rehab. 7:73-76, 1980.
 
21) Soskolne, W.A., Nuki, K., Raisz, L.G. and Allander, C.: The appearance of bone resorbing activity in ligature induced gingivitis in dogs. J. Perio. Res. 15:373-379, 1980.

22) Nuki, K., Soskolne, W.A., Raisz, L.G., Kornman, K. and Allader, C.: Bone resorbing activity of gingiva from Beagle dogs following Metranidazole and Indomethacin therapy. J. Perio. Res. 16:205-212, 1981.
 
23) Kornman, K., Siegrest, B., Soskolne, W.A. and Nuki, K.: The predominant cultivable subgingival flora of Beagle dogs following ligatire placement Metronidazole therapy. J. Perio. Res. 16:251-158, 1981.
 
24) Soskolne, W.A., Golomb, G., Friedman, M. and Sela, M.N.: New sustained release dosage form of chlorhexidine for dental use. J. Perio. Res. 18:330-336, 1983.
 
25) Atkin, I., Ornoy, A. and Soskolne, W.A.: Comparison of the effects of cortisone acetate on calcification, ossification and resorption of fetal mice ling bones in vivo and in vitro studies. Adv. Exp. Med. & Biol. 171:137-148, 1984.
 
26) Golomb, G., Friedman, M., Soskolne, W.A., Stabholz, A. and Sela, M.N.: Sustained release device containing metronidazole for periodontal use. J. Dent. Res. 63:1149-1153, 1984.
 
27) Bimstein, E., Lustman, J. and Soskolne, W.A.: Clinical and histometric study of gingivitis associated with human deciduous dentition. J. Periodontol. 56:293-196, 1985.
 
28) Schwartz, Z., Soskolne, W.A. and Ornoy, A.: The development of fetal mice long bones in vitro: a morphological study. Acta. Anat. 124:197-205, 1985.
 
29) Schwartz, Z., Goultschin, J. and Soskolne, W.A.: an Pproach to the treatment of advanced periodontal disease: a compromise. Comp. of Cont. Dent. Ed. 2:145-150, 1985.
 
30) Schwartz, Z., Nuki, K., Raisz, L.G. and Soskolne, W.A.: Inhibitory effects of human gingival extracts on bone resorption in vitro. J. Perio. Res. 21:455-461, 1986.

31) Soskolne, W.A., Schwartz, Z. and Ornoy, W.A.: The development of fetal mice long bones in vitro: an assay on bone modelling. Bone 7:41-48, 1986.
 
32) Bilostoky, L., Schwartz, Z. and Soskolne, W.A.: Undiagnosed intrusion of a maxillary primary incisor tooth: 15 year follow up. Pediat. Dent. 8:294-295, 1986.
 
33) Schwartz, Z., Ornoy, A. and Soskolne, W.A.: The effect of insulin and glucose on the modelling of long bones in vitro. Diabetic. Res. 3:321-326, 1986.
 
34) Stabholz, A., Selam M.N., Friedman, M., Golomb, G. and Soskolne, W.A.: Clinical and microbiological effects of sustained release chlorhexidine in periodontal pockets. J. Clin. Periodontol. 13:783-788, 1986.
 
35) Schwartz, Z., Soskolne, W.A. and Ornoy, A.: The physiology of vitamin D. Harefuah. 113:168-172, 1987. (Hebrew).
 
36) Schwartz, Z., Soskolne, W.A. and Ornoy, A.: The physiological effects of thyroid hormone on bone. Harefuah 113:168-172,1987 (Hebrew).
 
37) Bimstein, E., Soskolne, W.A., Lustman, J., Gazit, D. and Bab,I.: Gingivitis in the human deciduous dentition: a correlative clinical and block surface light microscopic(BSLM) study. J. Clin. Periodontol. 15:575-580, 1988.
 
38) Bimstein, E. and Soskolne, W.A.: A radiographic study of interproximal alveolar bone crest between the primary molars in children. J. Dent. child. 55:348-350, 1988.
 
39) Elkayam, R., Fridman, M., Stabholz, A., Soskolne, W.A., Sela,M.N. and Golub, L.: Sustained release device containing mincycline for local treatment of periodontal disease. J. Contr. Release, 7:231-236, 1988.
 
40) Schwartz, Z., Soskolne, W.A., Atkin, I., Goldstein, M. and Ornoy, A.: A direct effect of 24,25(OH)2D3 and 1,25(OH)2D3 on the modelling of fetal mice long bones in vitro. J. Bone Min. Res. 41:157-163, 1989.
 
41) Machtei, E., Zubery, Y., Ben Yehuda, A. and Soskolne, W.A.: Proximal bone loss adjacent to periodontally "Hopeless" teeth with and without extractions. J. Periodontol. 60:512-515,1989.
 
42) Soskolne, W.A. and Bimstein, E.: Apical migration of the junctional epithelium in human primary dentition as a multifactorial phenomenon. J. of Pedodontics 13:239-242, 1989
 
43) Stabholz, A., Soskolne, V., Machtei, E., Orr., R. and Soskolne, W.A.: Effect of benign familial neutropenia on the periodontium of Yemenite Jews. J. Periodontol. 61:51-54,1990
 
44) Stabholz, A., Soskolne, V., Machtei, E., Orr., R. and Soskolne, W.A.: Effect of benign familial neutropenia on the periodontium of Yemenite Jews. J. Periodontol. 61:51-54,1990.
 
45) Mazor, Z., Schwartz, Z. and Soskolne, W.A.: A conservative periodontal treatment combined with orthodontics as a treatment for "hopeless" anterior teeth - a case report. Am.J. Dent. 3:31-33, 1990.

46) Bimstein, E., Lustman, J., Sela M.N., Ben Neriah, Z. and Soskolne, W.A.: Periodontitis associated with Papillon Lefevre Syndrome. J. Periodontol. 61:373-377, 1990.
 
47) Goultschin, J., Sgan Cohen, H., Brayer, L., Donchin, M. and Soskolne, W.A.: Smoking and Periodontal treatments needs. J. Periodontol. 61:364-367, 1990.
 
48) Sgan Cohen, H., Donchin, M., Goultschin, J., Soskolne, W.A. and Brayer, L.: Periodontal treatment needs, by CPITN, among Jerusalem Hospital Employees. Accepted for publication. Isr.International Dental J. March 1991.
 
49) Steinberg, D., Friedman, M., Soskolne, W.A. and Sela, M.N.: A new biodegradable controlled release device for treatment of periodontal disease: in vitro release study. Accpeted for publication. J. Periodontol. 1990.
 
50) Soskolne, W.A., Schwartz, Z., Gouldstein, M. and Ornoy, A.: The biphasic effect of triiodothyronine compared to bone resorbing effect of PTH on bone medolling of mice long bone in vitro. Bone 11:301-307, 1990.
 
51) Shani, J., amir, D., Soskolne, W.A., Schwartz, Z., Chisin, R. and Sela, J.: Correlations between the uptake of technetium phosphate and mineralization in rat tibial bone repair. J. Nucl. Med. 31:2011-2014, 1990.

52) Friedman, M., Steinberg, D., Sela, M. and Soskolne, W.A.: Structural and microbiological evaluation of a degradable sustained release device for periodontal therapy. Accepted for publication. Drug Design and Delivery, 1990.
 
53) Stabholz, A., Soskolne, W.A., Friedman, M. and Sela, M.N.: The use of sustained release delivery of Chlorhexidine for maintenance of periodontal pockets. 2 year clinical trial. J. Periodontol. 62:429-433, 1991.
 
54) Z. Schwartz, W.A Soskolne, T. Neubauer, M. Goldstein, S. Adi,and A. Ornoy: Direct and Sex-Specific Enhancement of Bone Formation and Calcification by Sex Steroids in Fetal Mice Long Bone in vitro (Biochemical and Morphometric Study)Endocrinology, 129: 1167-1174, 1991.
 
55) Schwartz Z., Shani, D., Soskolne W.A., Tomma H., Amir D., Sela J: Uptake and Biodistribution of 99mTc-MDP, 99mTc-MD32P during bone rapair J Nucl, Med. 34:104-108, 1993.
 
56) Nasatsky, E., Schwartz, Z., Boyan, B.D., Soskolne, W.A., Ornoy, A., Sex dependent effects of 17 Beta-Estradiol on chondrocyte differentiation in culture. J. Cell Physiology 1992.
 
57) Shapira L., Takashiba S., Kalmar J., Van Dyke T.E., Barak V., Soskolne W.A.: Rapid fluorometric quantification of monocyte attachment in tissue culture wells. J. Immun. Methods 165:93-98,1993.
 
58) L. Shapira, W.A Soskolne, M.N. Sela, S. Offenbacher, V. Barak: The secretion of PGE2, IL-1b, IL-6 and TNFa by adherent Mononuclear Cells from Eearly Onset Periodontitis Patients. J. Periodontol. 65:139-146, 1994.

59) L. Shapira, S. Eizenberg, M.N. Sela, A. Soskolne, H. Brautbar: HLA A2 and B15 are Associated with the Generalized form, but not the Localized Form, of Early-Onset Periodontal Diseases. J. Period. 65:125-133, 1994.
 
60) Bimstein E, Matsson L, Soskolne AW, and Lustman J.: Histologic characteristics of the gingiva associated with the primary and permanent teeth of children. Ped. Dent. 16:206-210, 1994.
 
61) Roitberg-Tambur A, Friedmann A, Witt CS, Eisenberg S, Soskolne WA, Shapira L, Sela MN, Battat S, Safirman S and Brautbar C: HLA Polymorphism in Moroccan Jewry. Human Immunology 40:61-67, 1994.
 
62) Stabholz A, Taichman NS. Soskolne WA: Occurrence of actinobacillus actinomycetemcomitants and anti-leukotoxin antibodies in some members of an extended family affected by Papillon-Lefevre Syndrome. J. Periodontol. 653-657, Jul 1995.
 
63) Shapira L, Soskolne WA, Van Dyke TE: Prostaglandin E2 secretion, cell maturation and CD14 expression by monocyte-derived macrophages from localized juvenile periodontitis patients. J. Period., 67:224-228, 1996.
 
64) Shapira L, Houri I, Barak V, Halabi A, Soskolne WA, Stabholtz A: Human monocyte response to cementum extracts from periodontally diseased teeth: Effect of conditioning with tetracycline. J. Periodontol., 67:682-687, 1996.
 
65) Shapira L, Soskolne WA, Houri I, Barak V, Halabi A, Stabholtz A: Protection against endotoxic shock and lipopolysaccharide-induced local inflammation by tetracycline. Correlation with the inhibition of cytokine secretion. Infection and Immunity, 64:825-828, 1996
 
66) Bimstein E, Zaidenberg R, Soskolne WA: Alveolar bone loss and restorative dentistry in the primary molars. J. Clin. Pediatr. Dent., 21(1):51-54, 1996.
 
67) Soskolne WA, Stabholz A, TE Van Dyke, Hart TC, Meyle J: Partial expression of the Papillon-Lefevre syndrome in 2 unrelated families. J Clin Periodontol, 1996, 23:764-769.
 
68) Soskolne WA, Heasman PA, Stabholz A, Smart GJ, Palmer M, Flashner M, Newman HN: Sustained local delivery of chlorhexidine in the treatment of periodontitis: A multicenter study. J. Periodontol, 68:32-38, 1997.
 
69) Soskolne WA. Subgingival delivery of therapeutic agents in the treatment of periodontal diseases. Crit Rev Oral Biol Med, 8(2):164-174, 1997.
 
70) Shapira L, Soskolne A, Halabi A, Barak V, Stabholtz A: Induction of tumor necrosis factor a and interleukin-1b in subcutaneously implanted chamber by lipopoly-saccharide. J. Endotoxin Research, 4(5):325-329, 1997.
 
71) Shapira L, Sylvia V, Halabi A, Soskolne A, Van Dyke T, Dean D, Boyan B, Schwartz Z: Bacterial Lipopolysaccharide Induces Early and Late Activation of Protein Kinase C in Inflammatory Macrophages by Selective Activation of PKC-e. Biochemical and Biophysical Research Communications 240:629-634, 1997.
 
72) Soskolne WA: Subgingival Delivery of Therapeutic Agents in the Treatment of Periodontal Diseases. Crit Rev Oral Biol Med 8(2):164-174, 1997.
 
73) Hart TC, Stabholz A, Meyle J, Shapira L, Van Dyke TE, Cutler CW, Soskolne WA: Genetic studies of syndromes with severe periodontitis and palmoplantar hyperkeratosis. J. Periodontal Res., 32:81-89, 1997.
 
74) Nir-Hadar O, Palmer M, Soskolne WA. Delayed immediate implants: Alveolar bone changes during the healing period. Accepted for publication in Clinical Oral Implants Research, 1998.
 
75) Soskolne WA: Epidemiological and Clinical Aspects of Periodontal Diseases in Diabetics. J. Periodontol., Vol. 3, No.1, 1998.
 
76) Soskolne WA et al: An in vivo study of the chlorhexidine release profile of the PerioChipTM in the gingival crevicular fluid, plasma and urine. J Clin Periodontol, 25:1017-1021, 1998.
 
77) Frolov I, Houri-Hadad Y, Soskolne WA, Shapira L: In vivo exposure to Porphyromonas gingivalis up-regulates nitric oxide but supresses tumor necrosis factor a production by cultured macrophages. Immunology, 93:323-328, 1998.

78) Shapira L, Barak V, Soskolne WA, Halabi A, Stabholz A: Effect of tetracyclines on the pathologic activity of endotoxin. In vitro and in vivo studies. Adv. Dent. Res., 12:119-122, 1998.

79) Takashiba S, Van Dyke TE, Amar S, Murayama Y, SoskolneWA, Shapira L. Differentiation of monocytes to macrophages primes the cells for LPS stimulation via accumulation of cytoplasmic nuclear factor kB. Infection and Immunity, 67:5573-5578, 1999.

80) Houri-Haddad Y,  Soskolne WA, Halabi A, Barak V , Shapira L.  Repeat bacterial challenge in a subcutaneous chamber model results in augmented TNF-a and IFNg response, and suppression of IL-10.Immunology, 99:215-220, 2000.

81) Schwartz Z, Lohmann CH, Blau G, Blanchard CR, Soskolne WA, Cochran DL, Dean DD, and Boyan BD:  Re-use of implant coverscrews changes their surface properties but not clinical outcome.  Clin Oral Impl Res, in press.

82) Hart TC, Hart PS, Michalec M, Zhang Y, Firatli E, Van Dyke TE, Stabholz A, Zlotogorski A, Shapira L,  Soskolne A: Haim-Munk syndrome and Papillon-Lefevre   syndrome are allelic mutations in cathepsin C. J Med Genet, 37, in press.

83) Bimstein E, Soskolne WA, Lustmann J: Histomorphologic changes in the the gingiva and pulp of overretained primary teeth. J Dent Children, Nov-Dec 2000; 403-407.

84) Stabholz A, Shapira L, Mahler D, Gellman Y, Ramon T, Dolev E, Schwartz M, Berger L, Proskin HM, Finkelman RD, Flashner M, Kolatch B, Soskolne A. Using the PerioChipג in treating adult periodontitis: an interim report. Compendium, 21 (No.4):325-338, 2000.

85) Soskolne WA, Klinger A. The relationship between periodontal diseases and diabetes: an overview. Annals of Periodontology, 6:91-98, 2001.  

86) Houri-Haddad Y, Soskolne WA, Shapira L.  Immunization to Porphyromonas gingivalis enhances the local pro-inflammatory response to subcutaneous bacterial challenge. Journal of  Clinical Periodontology,  28:476-482, 2001.

87) Soskolne WA, Cohen S, Sennerby L, Wennerberg A, Shapira L. The effect of titanium surface roughness on the adhesion of monocytes and their secretion of TNFa and PGE2 . Clin Oral Impl Res. 13:86-93, 2002.

88) Houri-Haddad Y, Soskolne WA, Shai E, Palmon A, Shapira L.   Interferon-gamma deficiency attenuates local P. gingivalis-induced inflammation. Journal of  Dental Research 81(6):395-8, 2002. 

89) Ryder MI, Saghizadeh M, Ding Y, Nguyen N, Soskolne A. Effect of tobacco smoke on the secretion of IL-1b, TNF-a, PGE2, and TGFb from peripheral blood mononuclear cells. Oral Microbiol Immunol 17(6):331-6, 2002.

90) Klinger A, Goldstein M, Soskolne A, Goultschin J. Periodontal disease – an additional risk factor for cardiovascular disease. Refuat Hapeh Vehashinayim, 19(2):67-74, 2002.

91) Soskolne WA, Proskin HM, Stabholz A. Probing depth changes following 2 years of periodontal maintenance therapy including adjunctive controlled release of chlorhexidine. J Periodontol 74(4):420-7, 2003.

92)  Houri-Haddad Y, Karaka K, Stabholz A, Soskolne A, Shapira L. Tetracycline conditioning augments the in vivo inflammatory response induced by cementum extracts. J Periodontol 75(3):388-92, 2004.


CHAPTERS IN BOOKS

1) Smith, P., Soskolne, W.A. and Ornoy, A.: Morphological and histological changes inthe developing dentition of aborted human fetuses with a maternal history of rubella. Proceedings 4th International Conference on Dental Morphology ed., K.Joysey, Academic Press Chap. 12, p. 149-156, 1978.
 
2) Ornoy, A., Atkin, I. and Soskolne, W.A.: The effects of Triiodothyronine on fetal bone in mice: in vivo and in vitro studies. In Current Advances on Skeletogenesis. Development Biomineralization, Mediators and Metabolic Bone Diseases. pp 142-148 Ed. M. Silberman & H. Slavkin. Excerpta Medica,Amsterdam, 1982.
 
3) Merin, B., Ornoy, A. and Soskolne, W.A.: Transplacental effects of a single dose of hydrocortisone on fetal bones in rats. In current advance in skeletogenesis. Development, Biomineralization, Mediators and Metabolic bone dis 455-460. Ed. M. Silberman and H. Slavkin. Excerpta Medica, Amsterdam,1982.
 
4) Schwartz, Z., Ornoy, A. and Soskolne, W.A.: The effect of insulin and glucose on the modelling of fetal mice long bones in vitro. In: Proceedings of the 16th International workshop on clacified tissues. Kiryat Anavim, Israel. A. Ornoy, ed.,Elisiver Science Publication, Amsterdam p. 125 130, 1984.
 
5) Ornoy, A., Schwartz, Z., Atkin, I. and Soskolne, W.A.: The direct effects of vitamin D metabolites on bone modelling in fetal mice long bones grown in vitro. In: Vit. D. Chemical, Biochemical and Clinical update, Norman, A.W. et al efit.Walter de Gruyter Pub. 316-318, 1985.
 
6) Stbaholz, Z., Elkayam, R., Friedman, M., Sela, M., Azoury, R. and Soskolne, W.A.: Clinical and microbiological evaluation of sustained release device of tetracycline in periodontal pockets. Assoc. Pharm. Ind. 2:236-345, 1989.

7) Elkayam, R., Stabholz, A., Friedman, M., Soskolne, W.A. and Azoury, R.: Sustained release device of tetracycline for dental use: structure and kinetics of drug release in vitro and in vivo. Assoc. Pharm. Ind. 2:346-354, 1989.
 
8) Offenhacher, S., Soskolne, W.A., Van Dyke, T.E. and Arnold, R.R.: Crevicular fluid PGE2 as a marker for periodontal disease activity. In proceeding of the conference on risk assessment in dentistry. Edit. J. Bader Univ. North Carolina,Chapel Hill.
 
9) Van Dyke, T.E., Offenbacher, S., Kalmar, J., Arnold, R.R. and Soskolne, W.A.: Markers of periodontal disease susceptibility and activity present within the gingival crevicular fluid.In "Markers of disease susceptibility and activity for periodontal diseases". Edit. NW Johnsons, Pub. Royal Society of Medicine section Odontology (1991).
 
10) Offenbacher, S., Soskolne, W.A., Odle, B.M. & Collins, J.G.: Prostaglandis and other eicosanoids in gingival crevicular fluid as markers of periodontal disease susceptibility and activity. In "Markers of disease susceptibility and activity for periodontal diseases". Edit. NW Johnsons, Pub. Royal Society of Medicine section Odontology (1991).  

11) Soskolne, W.A., Freidman, M.: Intra-periodontal pocket drug delivery systems. In “Oral Mucosal Drug Delivery”. Edit. Michael Rathbone, Marcel Dekker Inc., New York, 1996.

12) Soskolne ,WA The Perio Chip: a biodegradable device for the controlled delivery of Chlorhexidine in the subgingival enviroment. In “ Modified-Release Drug Delivery Technology. Edit. Michael J Ratbone, Jonathan Hadgraft& Michael S. Roberts, Marcel Dekker Inc. New-York-In 2003.